Harmony Biosciences Files Proxy Materials
Ticker: HRMY · Form: DEFA14A · Filed: 2026-04-03T08:05:05-04:00
Sentiment: neutral
Topics: proxy-filing, sec-filing
Related Tickers: HRMY
TL;DR
HRMY filed proxy docs 4/3/26 - shareholder vote incoming.
AI Summary
Harmony Biosciences Holdings, Inc. filed a DEFA14A on April 3, 2026, which contains additional definitive proxy soliciting materials. The filing includes three documents: the main DEFA14A filing, and two graphic files, likely for presentation purposes. The company's business address is in Plymouth Meeting, PA.
Why It Matters
This filing indicates that Harmony Biosciences is engaging in proxy solicitations, which are crucial for shareholder voting on important company matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not inherently present new financial risks.
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Filer of the DEFA14A
- 0001104659-26-039453 (filing_id) — SEC Accession Number for the filing
- 2026-04-03 (date) — Filing Date
FAQ
What type of filing is this DEFA14A?
This is an Additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this filing submitted to the SEC?
The filing date was April 3, 2026.
What is the CIK number for Harmony Biosciences Holdings, Inc.?
The CIK number is 0001802665.
Where is Harmony Biosciences Holdings, Inc. located?
The company's mailing and business address is 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462.
What SIC code is associated with Harmony Biosciences Holdings, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001104659-26-039453 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: SEC Accession No. 0001104659-26-039453 Filing Date 2026-04-03 Accepted 2026-04-03 08:05:05 Documents 3 Document Format Files Seq Description Document Type Size 1 DEFA14A hrmy-20260403xdefa14a.htm DEFA14A 15766 2 GRAPHIC hrmy-20260403xdefa14a_bg001.jpg GRAPHIC 153140 3 GRAPHIC hrmy-20260403xdefa14a_bg002.jpg GRAPHIC 102796 Complete submission text file 0001104659-26-039453.txt 361962 Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800 Harmony Biosciences Holdings, Inc. (Filer) CIK : 0001802665 (see all company filings) EIN. : 822279923 | State of Incorp.: DE | Fiscal Year End: 1231 Type: DEFA14A | Act: 34 | File No.: 001-39450 | Film No.: 26836827 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)